MI Forecasts Phototherapy Treatment Market to Reach US$ 675 Million by 2026, with Strong Growth Potential

The Phototherapy Treatment Industry is on track to reach a substantial US$ 530 Million by the end of 2022 and is poised for further growth with a robust CAGR of 5% until 2026, culminating in an estimated market value of US$ 675 Million by 2026. Notably, acne remains a prevalent skin condition, especially among teenagers in the United States.

In the realm of contemporary dermatology, phototherapy has emerged as a highly effective and increasingly popular treatment option for both psoriasis and acne. It offers a cost-effective alternative to biologics while maintaining a high level of efficacy. As a result, the demand for phototherapy is expected to witness a significant upswing in regions like North America and Europe in the coming years.

A recent study by Future Market Insights (2017–2027) underscores this trend, projecting a noteworthy revenue growth in the North American and Europe phototherapy treatment industry at a compelling CAGR of 6.0% throughout the envisaged period.

Claim your complimentary report with captivating visuals.
https://www.futuremarketinsights.com/reports/sample/rep-gb-na-4297

The early beginning of acne in youngsters is associated with distorted eating patterns as well as excessive consumption of fried and ready-to-eat food products. Women also experience the emergence of severe acne and psoriasis as adults. The most lucrative market for phototherapy is North America, followed by Western Europe and Eastern Europe, according to a report titled “Phototherapy Treatment Market for Acne and Psoriasis North America and Europe Industry Analysis 2012 – 2016 and Opportunity Assessment; 2017 – 2027.” According to projections, the North American market would increase from US$ 594.5 Mn in 2016 to US$ 1,150.0 Mn by the end of 2027. Additionally, the U.S. currently controls more than three-fourths of the market for phototherapy treatments in North America.

The increasing adoption of phototherapy in dermatology clinics and hospitals in Europe is favouring the growth of the market in the region. Moreover, psychological burdens associated with acne and psoriasis are high in the region, compelling patients to seek professional help in the form of prescription treatments, phototherapy, and others. Germany and the UK are two of the major markets for phototherapy in Europe and are expected to remain dominant throughout the forecast period.

Methodology Details Just a Click Away!

https://www.futuremarketinsights.com/request-report-methodology/rep-gb-na-4297

Key Excerpts from the Report Include:

• Based on end users, hospitals currently account for the largest value share of the phototherapy treatment market for acne and psoriasis in North America and Europe. However, the preference for home care settings among patients is likely to grow shortly.
• Demand for blue light therapy is relatively higher than other phototherapy types in both North America and Europe. This trend is expected to continue throughout the assessment period. The blue light phototherapy segment is estimated to reach a market valuation of US$ 1,067.1 Mn towards the end of 2027.

Phototherapy being a high-margin reconstructive technology is perceived as an opportunity for market players to invest in future growth.

• Lifespan,
• UC Irvine Health,
• Buffalo Medical Group,
• Blackrock Clinic Limited,
• The Private Phototherapy Clinic Ltd.,
• National Skin Centre,
• and Massachusetts General Hospital

Get Ahead with Comprehensive Information – Purchase Now!
https://www.futuremarketinsights.com/checkout/4297

North America and Europe Phototherapy Treatment for Acne and Psoriasis Market – Taxonomy

By Disease Type

• Psoriasis
  • Guttate Psoriasis
  • Inverse Psoriasis
  • Pustular Psoriasis
  • Erythrodermic Psoriasis
  • Plaque Psoriasis
• Acne
  • Acne Vulgaris
  • Acne Conglobata
  • Acne Fulminans
  • Gram-Negative Folliculitis
  • Acne Rosacea
  • Pyoderma Faciale

By Phototherapy Type

• Blue Light Phototherapy
• Red Light Phototherapy
• Intense Pulsed Light (IPL) Phototherapy
• Narrowband UVB Phototherapy
• Psoralens+Ultravioletlight A (PUVA) Phototherapy

By End User

• Hospitals
• Dermatology Clinics/Skin Care Centres
• Wellness Centres
• Home Care Settings

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube